SWBI vs. GMRE
Compare and contrast key facts about Smith & Wesson Brands, Inc. (SWBI) and Global Medical REIT Inc. (GMRE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SWBI or GMRE.
Performance
SWBI vs. GMRE - Performance Comparison
Returns By Period
In the year-to-date period, SWBI achieves a 0.27% return, which is significantly higher than GMRE's -15.84% return.
SWBI
0.27%
1.92%
-16.32%
-2.29%
18.14%
7.46%
GMRE
-15.84%
-7.03%
5.33%
-2.81%
-1.09%
N/A
Fundamentals
| SWBI | GMRE | |
|---|---|---|
| Market Cap | $582.63M | $598.67M |
| EPS | $0.74 | -$0.02 |
| Total Revenue (TTM) | $384.97M | $145.46M |
| Gross Profit (TTM) | $123.76M | $93.11M |
| EBITDA (TTM) | $66.03M | $100.67M |
Key characteristics
| SWBI | GMRE | |
|---|---|---|
| Sharpe Ratio | -0.04 | -0.09 |
| Sortino Ratio | 0.29 | 0.05 |
| Omega Ratio | 1.04 | 1.01 |
| Calmar Ratio | -0.03 | -0.05 |
| Martin Ratio | -0.11 | -0.14 |
| Ulcer Index | 15.10% | 16.42% |
| Daily Std Dev | 43.90% | 25.65% |
| Max Drawdown | -99.49% | -58.92% |
| Current Drawdown | -58.43% | -40.14% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between SWBI and GMRE is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
SWBI vs. GMRE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Smith & Wesson Brands, Inc. (SWBI) and Global Medical REIT Inc. (GMRE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SWBI vs. GMRE - Dividend Comparison
SWBI's dividend yield for the trailing twelve months is around 3.77%, less than GMRE's 9.62% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
SWBI Smith & Wesson Brands, Inc. | 3.77% | 3.39% | 4.38% | 1.63% | 0.56% | 0.00% | 0.00% | 0.00% | 0.00% |
GMRE Global Medical REIT Inc. | 9.62% | 7.57% | 8.86% | 4.62% | 6.13% | 6.05% | 9.00% | 9.76% | 4.48% |
Drawdowns
SWBI vs. GMRE - Drawdown Comparison
The maximum SWBI drawdown since its inception was -99.49%, which is greater than GMRE's maximum drawdown of -58.92%. Use the drawdown chart below to compare losses from any high point for SWBI and GMRE. For additional features, visit the drawdowns tool.
Volatility
SWBI vs. GMRE - Volatility Comparison
Smith & Wesson Brands, Inc. (SWBI) has a higher volatility of 9.89% compared to Global Medical REIT Inc. (GMRE) at 6.04%. This indicates that SWBI's price experiences larger fluctuations and is considered to be riskier than GMRE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SWBI vs. GMRE - Financials Comparison
This section allows you to compare key financial metrics between Smith & Wesson Brands, Inc. and Global Medical REIT Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities